Cochlear (COH) Stock Overview
Provides implantable hearing solutions for children and adults worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
COH passed our risk checks.
COH Community Fair Values
Create NarrativeSee what 53 others think this stock is worth. Follow their fair value or set your own to get alerts.
Cochlear Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$288.39 |
| 52 Week High | AU$323.00 |
| 52 Week Low | AU$246.14 |
| Beta | 0.46 |
| 1 Month Change | 1.57% |
| 3 Month Change | -7.95% |
| 1 Year Change | -3.68% |
| 3 Year Change | 40.97% |
| 5 Year Change | 23.39% |
| Change since IPO | 9,675.93% |
Recent News & Updates
Does Cochlear (ASX:COH) Deserve A Spot On Your Watchlist?
Oct 14
We Think Cochlear (ASX:COH) Might Have The DNA Of A Multi-Bagger
Sep 28Recent updates
Does Cochlear (ASX:COH) Deserve A Spot On Your Watchlist?
Oct 14We Think Cochlear (ASX:COH) Might Have The DNA Of A Multi-Bagger
Sep 28Cochlear (ASX:COH) Is Due To Pay A Dividend Of A$2.15
Aug 26Cochlear Limited's (ASX:COH) Shares May Have Run Too Fast Too Soon
Jul 16Here's Why We Think Cochlear (ASX:COH) Might Deserve Your Attention Today
Jun 13Why You Should Care About Cochlear's (ASX:COH) Strong Returns On Capital
May 26Unpleasant Surprises Could Be In Store For Cochlear Limited's (ASX:COH) Shares
Apr 05Cochlear (ASX:COH) Will Pay A Larger Dividend Than Last Year At A$2.15
Mar 06Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching
Feb 23
New Cochlear Implant Launch And Market Expansion Will Strengthen Future Prospects
Focus on adult and senior markets in developed countries could drive revenue and net margin growth through increased sales volume.Is Cochlear Limited (ASX:COH) Worth AU$310 Based On Its Intrinsic Value?
Feb 08Earnings Not Telling The Story For Cochlear Limited (ASX:COH)
Dec 20Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital
Nov 19Shareholder Returns
| COH | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 2.7% | -0.8% | -0.9% |
| 1Y | -3.7% | -2.3% | 6.7% |
Return vs Industry: COH underperformed the Australian Medical Equipment industry which returned -2.3% over the past year.
Return vs Market: COH underperformed the Australian Market which returned 6.7% over the past year.
Price Volatility
| COH volatility | |
|---|---|
| COH Average Weekly Movement | 2.5% |
| Medical Equipment Industry Average Movement | 11.2% |
| Market Average Movement | 9.6% |
| 10% most volatile stocks in AU Market | 19.9% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: COH has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: COH's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 5,500 | Dig Howitt | www.cochlear.com |
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories.
Cochlear Limited Fundamentals Summary
| COH fundamental statistics | |
|---|---|
| Market cap | AU$18.56b |
| Earnings (TTM) | AU$388.90m |
| Revenue (TTM) | AU$2.34b |
Is COH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COH income statement (TTM) | |
|---|---|
| Revenue | AU$2.34b |
| Cost of Revenue | AU$615.20m |
| Gross Profit | AU$1.73b |
| Other Expenses | AU$1.34b |
| Earnings | AU$388.90m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Feb 13, 2026
| Earnings per share (EPS) | 5.95 |
| Gross Margin | 73.74% |
| Net Profit Margin | 16.60% |
| Debt/Equity Ratio | 0% |
How did COH perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/11 07:43 |
| End of Day Share Price | 2025/11/11 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cochlear Limited is covered by 24 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Stuart Roberts | Bell Potter |
| Lyanne Harrison | BofA Global Research |